Insoluble fractions of human postmortem brain samples from patients with late-stage AD showed a higher level of RIPK1, RIPK3, and MLKL as compared with standard age-matched brain samples and positively correlated with the reduction of brain weights and Braak stages [79,80]. This evidence concerns the gene MLKL and Alzheimer disease.